Patient demographics
| Variable | Time (months) | COVID-19 (n=56) | Control (n=14) | P value |
| Age | 5 | 40.7±10.1 | 41.0±8.3 | 0.92 |
| Sex (M/F ratio) | 5 | 0.85/0.14 | 0.79/0.21 | 0.68 |
| Height | 5 | 177.2±8.4 | 177.4±7.7 | 0.94 |
| Body mass (kg) | 5 | 91.8±14.7 | 80.9±10.1 | 0.01 |
| 12 | 93.0±15.4 | 80.3±8.8 | <0.01 | |
| 18 | 94.4±14.8 | 81.2±9.1 | <0.01 | |
| BMI | 5 | 29.2±3.8 | 25.7±2.9 | <0.01 |
| 12 | 29.7±4.0 | 25.5±2.7 | <0.01 | |
| 18 | 30.3±4.1 | 26.0±2.8 | <0.01 | |
| Waist circumference (cm) | 5 | 96.8±11.3 | 87.6±9.1 | 0.01 |
| 12 | 98.2±12.9 | 83.6±10.9 | <0.01 | |
| 18 | 101.1±11.4 | 89.6±8.0 | <0.01 | |
| Hip circumference (cm) | 5 | 103.5±8.8 | 95.9±7.2 | <0.01 |
| 12 | 102.3±10.5 | 94.5±5.5 | <0.01 | |
| 18 | 103.8±8.8 | 96.1±5.5 | <0.01 | |
| Waist:hip ratio | 5 | 0.94±0.08 | 0.92±0.08 | 0.391 |
| 12 | 0.96±0.08 | 0.88±0.1 | <0.01 | |
| 18 | 0.97±0.06 | 0.93±0.07 | 0.04 |
Seventy participants recorded data at all three time points (5, 12 and 18 months). Of the 70 participants, 56 were exposed to COVID-19 and 14 acted as controls.
The bold font is just to highlight were there is statistical significance p<0.05.
BMI, body mass index; M/F, male/female.